your information resource in human molecular genetics
The U.S. Food and Drug Administration approved the first totally implanted artificial heart for patients with advanced heart failure in both of the heart�s pumping chambers. The device is intended for patients who are not eligible for a heart transplant and whose life expectancy without the device is only a month. Heart failure is a serious condition in which the heart is unable to pump enough blood throughout the body. About 5 million people in the United States have heart failure and it contributes to or causes about 300,000 deaths every year.
The approval of the totally implanted artificial heart is a significant milestone as there are few options for heart failure patients with the most severe form of the disease and who are in critical need.
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.